The obesity‐associated signalling entails hyperacetylation of PGC‐1α,71 and induction of pAMPK, PGC‐1α, NRF‐1 and TFAM (after the salicylate treatment of pre‐adipocytes).29 This evidence concerns the gene PPARGC1A and obesity disorder.